SCOTT WOJCIECHOWSKI: Open Payments
NPI 1477598886 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 16 payments from 11 companies in 2025. Trend: 2023 $46 · 2024 $370 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Biosense Webster, Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $38 |
| CVRx, Inc. | 2 | $32 |
| PFIZER INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Amgen Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Kerendia, CARTO 3, Wegovy, Barostim Neo System, VYNDAQEL, CAMZYOS, VERQUVO, REPATHA.
Industry payments across FL — which companies pay providers there.
